Correlation Between Sight Sciences and Bone Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sight Sciences and Bone Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sight Sciences and Bone Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sight Sciences and Bone Biologics Corp, you can compare the effects of market volatilities on Sight Sciences and Bone Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sight Sciences with a short position of Bone Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sight Sciences and Bone Biologics.

Diversification Opportunities for Sight Sciences and Bone Biologics

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between Sight and Bone is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Sight Sciences and Bone Biologics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bone Biologics Corp and Sight Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sight Sciences are associated (or correlated) with Bone Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bone Biologics Corp has no effect on the direction of Sight Sciences i.e., Sight Sciences and Bone Biologics go up and down completely randomly.

Pair Corralation between Sight Sciences and Bone Biologics

Given the investment horizon of 90 days Sight Sciences is expected to under-perform the Bone Biologics. But the stock apears to be less risky and, when comparing its historical volatility, Sight Sciences is 1.26 times less risky than Bone Biologics. The stock trades about -0.29 of its potential returns per unit of risk. The Bone Biologics Corp is currently generating about -0.19 of returns per unit of risk over similar time horizon. If you would invest  171.00  in Bone Biologics Corp on August 24, 2024 and sell it today you would lose (48.00) from holding Bone Biologics Corp or give up 28.07% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Sight Sciences  vs.  Bone Biologics Corp

 Performance 
       Timeline  
Sight Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sight Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Bone Biologics Corp 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady essential indicators, Bone Biologics reported solid returns over the last few months and may actually be approaching a breakup point.

Sight Sciences and Bone Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sight Sciences and Bone Biologics

The main advantage of trading using opposite Sight Sciences and Bone Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sight Sciences position performs unexpectedly, Bone Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bone Biologics will offset losses from the drop in Bone Biologics' long position.
The idea behind Sight Sciences and Bone Biologics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets